Discovery of 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a Novel Highly Selective α4β2 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders-Reference-Cited by-同舟云学术

Discovery of 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a Novel Highly Selective α4β2 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders

Published:2012-07-27 Issue:21 Volume:55 Page:9181-9194
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Mazurov Anatoly A.¹,Miao Lan¹,Bhatti Balwinder S.¹,Strachan Jon-Paul¹,Akireddy Srinivasa¹,Murthy Srinivasa¹,Kombo David¹,Xiao Yun-de¹,Hammond Philip¹,Zhang Jenny¹,Hauser Terry A.¹,Jordan Kristen G.¹,Miller Craig H.¹,Speake Jason D.¹,Gatto Gregory J.¹,Yohannes Daniel¹

Affiliation:

1. Targacept, Inc., Winston Salem, North Carolina 27101, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm3006542

Reference54 articles.

1. Nicotinic acetylcholine receptors and the regulation of neuronal signalling

2. Neuronal Nicotinic Acetylcholine Receptors: Structural Revelations, Target Identifications, and Therapeutic Inspirations

3. Nicotinic receptors as targets for therapeutic discovery